Effects of different types of dietary fat on liver and heart health
Official title: The Effect of Short-term Overconsumption of Specific Dietary Nutrients on Liver and Adipose Tissue Metabolism.
Run by University of Oxford · NCT05962190 · Data updated 2026-11-12
This study tests how eating different types of fats affects liver and heart health in healthy adults over 28 days.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 26 (estimated) |
| Sponsor | University of Oxford Academic / other |
| Locations | 1 site (Oxford) |
| Status | Recruiting |
| Started | February 15, 2023 |
| Main results expected | February 2028 |
| Study ends | February 2028 |
| Registry record updated | July 27, 2023 |
| Trial ID | NCT05962190 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy men and women aged 18 to 65 with a stable body weight and a BMI between 19 and 35.
✕Probably not a fit
Patients with metabolic conditions, significant weight fluctuations, or those on relevant drug therapies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates how the consumption of saturated versus unsaturated fatty acids affects liver fat, cardiac function, and metabolism in healthy adults. Participants will follow a high-fat diet for 28 days, with assessments including MRI scans to measure liver and cardiac fat, as well as metabolic responses to a test meal. The goal is to understand the impact of dietary fat composition on metabolic health without changes in body weight.
Why it matters
Potential benefit: If successful, this study could provide insights into dietary recommendations for improving liver and heart health.
How similar studies have gone: Previous studies have explored dietary fat impacts on metabolism, but this specific comparison of saturated and unsaturated fats in a controlled setting is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The participant is willing and able to give informed consent for participation in the study. * Male or Female, aged ≥18 or ≤65 years. * Body Mass Index ≥19 ≤35 kg/m2 * No medical condition or relevant drug therapy that is known to affect liver or adipose tissue metabolism. * Weight stable for the previous 3 months Exclusion Criteria: * The participant is unwilling or unable to give informed consent for participation in the study. - Aged ≤18 or ≥65 years * Body Mass Index ≤19 or ≥35kg/m2 * Blood haemoglobin \<135mg/dL for men and \<120mg/dL for women * Donated (or lost) ≥250 ml of blood in the previous two months. * On a weight loss diet or have decreased their body weight by \>5% in the previous 3 months. * Have increased their body weight by \>5% in the previous 3 months. * Any metabolic condition or relevant drug therapy * Current smoker * History of alcoholism or a greater than recommended alcohol intake (\>30 g of alcohol daily for men and \>20 g of alcohol daily for women) * Haemorrhagic disorders * Anticoagulant treatment * History of albumin allergy * Pregnant or nursing mothers * Women prescribed any contraceptive agent or device including oral contraceptives, hormone replacement therapy (HRT) or who have used these within the last 12 months History of severe claustrophobia * Presence of metallic implants, pacemakers, or are unwilling to remove any piercings * History of an eating disorder or any other psychological condition that may affect the participant's ability to adhere to study intervention/experimental diets.
Where it's running
-
Oxford Centre for Diabetes, Endocrinology and Metabolism
Oxford, United Kingdom Recruiting
Study contacts
- Principal investigator: Leanne Hodson, PhD — University of Oxford
- Study coordinator: Leanne Hodson
- Email: leanne.hodson@ocdem.ox.ac.uk
- Phone: 01865 857224
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CTX310 for refractory high triglycerides or LDL cholesterol
This trial will test whether a single IV dose of CTX310 is safe and tolerated in adults whose high triglycerides or LDL cholesterol have not responded to available treatments.
-
Levothyroxine for heart function in children with subclinical hypothyroidism
This trial will test whether levothyroxine improves heart function in children aged 4–15 who have subclinical hypothyroidism.
-
Genotype-based versus standard dietary counseling to reduce weight and body fat.
This test sees if dietary advice based on your genes helps Greek adults with overweight lose more weight and reduce body fat compared with standard dietary advice.
-
Non-invasive blood and imaging tests for metabolic liver disease
This project tests whether blood tests and imaging scans can diagnose and stage metabolic-associated steatohepatitis (MASH) and liver fibrosis in adults with metabolic risk factors.
-
Combining Probucol with Statins for Ischemic Stroke Treatment
This study is testing if adding Probucol to standard statin treatment can help adults who have had an ischemic stroke and have atherosclerosis by reducing plaque buildup and preventing future strokes or heart problems.
-
Investigating how low-intensity ultrasound affects heart function
This study is testing whether low-intensity ultrasound can improve heart function and how it affects heart rhythms in participants.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.